EXACT Ebitda vs Income Before Tax Analysis
EXAS Stock | USD 51.23 0.72 1.39% |
EXACT Sciences financial indicator trend analysis is much more than just examining EXACT Sciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether EXACT Sciences is a good investment. Please check the relationship between EXACT Sciences Ebitda and its Income Before Tax accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.
Ebitda vs Income Before Tax
Ebitda vs Income Before Tax Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of EXACT Sciences Ebitda account and Income Before Tax. At this time, the significance of the direction appears to have almost identical trend.
The correlation between EXACT Sciences' Ebitda and Income Before Tax is 0.93. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Income Before Tax in the same time period over historical financial statements of EXACT Sciences, assuming nothing else is changed. The correlation between historical values of EXACT Sciences' Ebitda and Income Before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of EXACT Sciences are associated (or correlated) with its Income Before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Before Tax has no effect on the direction of Ebitda i.e., EXACT Sciences' Ebitda and Income Before Tax go up and down completely randomly.
Correlation Coefficient | 0.93 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Ebitda
Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on EXACT Sciences income statement and is an important metric when analyzing EXACT Sciences profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most indicators from EXACT Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into EXACT Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.At this time, EXACT Sciences' Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 2.5 M in 2024, despite the fact that Enterprise Value Over EBITDA is likely to grow to (1.1 K).
2021 | 2022 | 2023 | 2024 (projected) | Non Recurring | 20.2M | 16.0M | 14.4M | 13.7M | Reconciled Depreciation | 180.3M | 197.6M | 206.6M | 131.5M |
EXACT Sciences fundamental ratios Correlations
Click cells to compare fundamentals
EXACT Sciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
EXACT Sciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 3.5B | 4.9B | 6.7B | 6.2B | 6.5B | 6.8B | |
Total Stockholder Equity | 2.3B | 2.8B | 3.4B | 3.0B | 3.1B | 3.3B | |
Net Debt | 769.0M | (27.1M) | 2.0B | 2.2B | 1.9B | 2.0B | |
Cash | 177.3M | 1.5B | 315.5M | 242.5M | 605.4M | 635.6M | |
Other Assets | 20.3M | 63.8M | 74.6M | 36.7M | 42.2M | 44.3M | |
Cash And Short Term Investments | 323.7M | 1.8B | 1.0B | 632.1M | 777.6M | 816.5M | |
Common Stock Shares Outstanding | 131.3M | 151.1M | 171.3M | 176.4M | 180.1M | 189.2M | |
Liabilities And Stockholders Equity | 3.5B | 4.9B | 6.7B | 6.2B | 6.5B | 6.8B | |
Other Stockholder Equity | 3.4B | 4.8B | 6.0B | 6.3B | 6.6B | 6.9B | |
Total Liab | 1.2B | 2.1B | 3.3B | 3.2B | 3.3B | 3.5B | |
Total Current Assets | 557.0M | 2.2B | 1.4B | 982.3M | 1.2B | 1.3B | |
Other Current Liab | 8.5M | 38.3M | 31.0M | 306.4M | 14.8M | 20.2M | |
Total Current Liabilities | 236.5M | 575.8M | 517.1M | 412.7M | 514.7M | 540.4M | |
Property Plant And Equipment Net | 581.8M | 576.6M | 754.5M | 851.8M | 842.1M | 884.2M | |
Retained Earnings | (1.1B) | (2.0B) | (2.6B) | (3.3B) | (3.5B) | (3.3B) | |
Accounts Payable | 26.0M | 35.7M | 67.8M | 74.9M | 78.8M | 82.8M | |
Non Current Assets Total | 2.9B | 2.7B | 5.3B | 5.2B | 5.3B | 5.5B | |
Non Currrent Assets Other | 20.3M | (193.1M) | (451.3M) | (425.5M) | (287.5M) | (273.2M) | |
Common Stock Total Equity | 1.5M | 1.6M | 1.7M | 1.8M | 2.0M | 2.1M | |
Other Current Assets | 40.9M | 33.2M | 74.1M | 73.9M | 85.6M | 89.9M | |
Property Plant And Equipment Gross | 581.8M | 576.6M | 754.5M | 851.8M | 1.3B | 1.3B | |
Accumulated Other Comprehensive Income | (100K) | 526K | (1.4M) | (5.2M) | 1.4M | 1.5M | |
Common Stock | 1.5M | 1.6M | 1.7M | 1.8M | 1.8M | 1.9M | |
Intangible Assets | 1.1B | 848.4M | 2.1B | 2.0B | 1.9B | 2.0B | |
Property Plant Equipment | 455.3M | 450.7M | 754.5M | 684.8M | 787.5M | 826.8M | |
Good Will | 1.2B | 1.2B | 2.3B | 2.3B | 2.4B | 2.5B | |
Other Liab | 28.1M | 61.6M | 417.8M | 345.1M | 396.8M | 416.7M | |
Short Term Investments | 146.4M | 348.7M | 715.0M | 389.6M | 172.3M | 222.6M | |
Non Current Liabilities Total | 981.2M | 1.5B | 2.8B | 2.8B | 2.8B | 3.0B | |
Current Deferred Revenue | 193.3M | 233.6M | 398.6M | 3.1M | 341.7M | 358.8M | |
Short Long Term Debt Total | 946.3M | 1.5B | 2.4B | 2.4B | 2.6B | 2.7B | |
Long Term Debt | 827.6M | 1.3B | 2.2B | 2.2B | 2.3B | 2.4B | |
Net Tangible Assets | (58.7M) | 737.4M | (1.0B) | 697.1M | 627.4M | 658.8M | |
Retained Earnings Total Equity | (1.1B) | (2.0B) | (2.6B) | (3.3B) | (2.9B) | (2.8B) | |
Long Term Debt Total | 4.3M | 688.8M | 827.6M | 2.2B | 2.5B | 2.6B | |
Capital Surpluse | 3.4B | 4.8B | 6.0B | 6.3B | 7.3B | 7.6B | |
Inventory | 61.7M | 92.3M | 105.0M | 118.3M | 127.5M | 133.8M | |
Non Current Liabilities Other | 34.9M | 61.6M | 417.8M | 352.5M | 336.0M | 352.8M | |
Short Term Debt | 8.7M | 268.3M | 19.7M | 28.4M | 79.4M | 83.3M |
Pair Trading with EXACT Sciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EXACT Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EXACT Sciences will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to EXACT Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EXACT Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EXACT Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EXACT Sciences to buy it.
The correlation of EXACT Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EXACT Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EXACT Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EXACT Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.Note that the EXACT Sciences information on this page should be used as a complementary analysis to other EXACT Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for EXACT Stock analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is EXACT Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EXACT Sciences. If investors know EXACT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.31) | Revenue Per Share 13.998 | Quarterly Revenue Growth 0.058 | Return On Assets (0.03) | Return On Equity (0.08) |
The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EXACT Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if EXACT Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EXACT Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.